ProductsProprietary Products

WinRho

Therapeutic indication:

WinRho® SDF is a Rho(D) Immune Globulin Intravenous (Human) (anti-D) product that is indicated for the treatment of ITP in Rho(D)-positive patients and for the suppression of Rh isoimmunization in non-sensitized Rho(D)-negative patients.

  • Composition: Rho(D) Immune Globulin Intravenous (Human) (anti-D)
  • Pharmaceutical form: Solution for Intravenous or Intramuscular Injection
  • Method of administration: Intravenous or Intramuscular Injection
  • Manufacturer: Kamada